Reports 11 Nov 2020 Navigating the Immunotherapy Maze …treatments, these approaches are revolutionizing the way we treat cancer and autoimmune diseases. As the first immunotherapies on the market, antibodies make up the largest group of immunotherapies. In recent… November 11, 2020 - 2 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Interview 18 Apr 2018 What Lies Ahead for European Cell and Gene Therapies? Cell and gene therapies have recently made big advances in providing effective treatments for a variety of conditions, from cancers to rare diseases. Nonetheless, there are still significant challenges ahead… April 18, 2018 - 5 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 24 Nov 2022 AI works on artificial DNA for future drug development …contribute to the development and production of vaccines, drugs for severe diseases, as well as alternative food proteins much faster and at significantly lower costs than today. How our genes… November 24, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 21 Feb 2023 FDA approves alpha-mannosidosis drug Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), says the U.S. Food and Drug Administration (FDA) has approved Lamzede (velmanase… February 21, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 25 Aug 2022 3T Biosciences launches with $40M financing 3T Biosciences wants to change the future of treatment for solid tumors and other immune-mediated diseases. And it exited from stealth today backed by $40 million in series A financing… August 25, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 28 May 2025 Myasthenia gravis treatments: what’s on the horizon? …Immunology Therapeutic Area at Johnson & Johnson Innovative Medicine, called the FDA win a “historic milestone” for more than 240 million people living with autoantibody diseases in the U.S., many… May 28, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 4 Dec 2017 Swiss Biotech Brings in Reinforcements to See Hypertension Drug Through Phase III …$30B (€27.9B) acquisition by Johnson & Johnson, retaining all of the former biotech’s early-stage assets. The company develops small molecules for a broad range of diseases and has announced that… December 4, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Jun 2019 The Top 20 Industrial Biotechnology Companies in Europe …kind of material. Metabolic Explorer Founded: 1999 Location: St-Beauzire, France A spin-off from the Université d’Auvergne, Metabolic Explorer has the goal of offering alternatives to petrochemicals in all industries. Its… June 19, 2019 - 8 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 15 May 2020 Synthetic Biology Could Lead to Clean Energy Using Light and Carbon Dioxide …in using our artificial chloroplasts in high-throughput screening of enzymes and prototyping metabolic pathways.” The team’s photosynthetic droplets of approximately 90 microns in diameter. As an example of the immediate… May 15, 2020 - 3 minutesmins - By David Kirk Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2017 Mind the Gut: Copenhagen Exhibition Explores Bacteria and Feelings …nervous diseases used in the 19th century to treat mental conditions such as stress and anxiety. Right: mouse metabolic chamber used at the Novo Nordisk Foundation Center for Basic Metabolic… October 7, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 18 Nov 2022 New discovery gives hope in fight against metastatic cancer …into how the metastases adapt to their new environment. “Obviously, the local environment affects the cancer cells more than previously known. The metastatic tumors should show the same metabolic properties… November 18, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 4 May 2023 Osteoporosis drug helps T cells fight aggressive breast cancer …stem cells make them invisible to the immune system. Counteracting the metabolic change with the drug zolendronate could make immunotherapy using gamma delta T cells more efficient against TNBC. The… May 4, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email